Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Hund

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 3, 2025
Whole Slide Image vs Microscope Glass Slide Performance for the Evaluation of Programmed Death-Ligand 1 (PD-L1) Expression in 14 Tumor Types Using PD-L1 IHC 22C3 pharmDxMicki Adams, Deanna Moquin, Siena Tabuena-Frolli, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 11, 2021
Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDxMegan Kalpakoff, Stephanie Hund, Jeanette Musser, et al.
The Journal of Pathology. Clinical Research|April 17, 2024
Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119Javier Cortes, Eric P Winer, Oleg Lipatov, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 3, 2025
Whole Slide Image vs Microscope Glass Slide Performance for the Evaluation of Programmed Death-Ligand 1 (PD-L1) Expression in 14 Tumor Types Using PD-L1 IHC 22C3 pharmDxMicki Adams, Deanna Moquin, Siena Tabuena-Frolli, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 11, 2021
Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDxMegan Kalpakoff, Stephanie Hund, Jeanette Musser, et al.
The Journal of Pathology. Clinical Research|April 17, 2024
Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119Javier Cortes, Eric P Winer, Oleg Lipatov, et al.
Pageof 1